• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌拉西林/他唑巴坦与庆大霉素及环丙沙星的体外药效学研究

In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin.

作者信息

Gould I M, Milne K

机构信息

Department of Medical Microbiology, Aberdeen Royal Hospital NHS Trust, Aberdeen Royal Infirmary, UK.

出版信息

J Antimicrob Chemother. 1997 Jan;39(1):53-61. doi: 10.1093/jac/39.1.53.

DOI:10.1093/jac/39.1.53
PMID:9044028
Abstract

Six isolates each of Enterococcus faecium, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Stenotrophomonas maltophilia, Pseudomonas aeruginosa, Citrobacter spp., Serratia spp., Acinetobacter spp. and Enterobacter spp. (total 60 strains) were studied against the combination of piperacillin/tazobactam plus gentamicin or ciprofloxacin at physiological concentrations by the microtitre chequerboard method incorporating simultaneous time-kill curves. Tazobactam was fixed at 4 mg/L. Gentamicin plus piperacillin/tazobactam was a synergic combination against 28 strains at 2 h, 51 at 5 h and 54 at 24 h as assessed by time-kill curves and synergic or additive (FBC index < or = 1) against all 60 strains at 24 h by chequerboards. The corresponding figures for ciprofloxacin plus piperacillin/tazobactam were seven, 26, 52 and 58 respectively. Antagonism (FBC index > or = 4) was demonstrated for one strain to each combination at 24 h. There were no significant differences between FIC indices and FBC indices for each antibiotic combination. Gentamicin plus piperacillin/tazobactam gave > or = 3 log kill for 47 strains by 2 h, 56 by 5 h and 59 by 24 h. Ciprofloxacin plus piperacillin/tazobactam gave > or = 3 log kill for 22 strains by 2 h, 36 by 5 h and 56 by 24 h. In conclusion both antibiotic combinations at physiological concentrations were synergic or additive at 24 h for the majority of strains tested although notably gentamicin plus piperacillin/tazobactam gave faster kill. Antagonism was rarely seen. Both combinations are likely to prove beneficial for treatment of serious infections.

摘要

采用微量滴定棋盘法并结合同步时间杀菌曲线,研究了粪肠球菌、金黄色葡萄球菌、表皮葡萄球菌、化脓性链球菌、嗜麦芽窄食单胞菌、铜绿假单胞菌、柠檬酸杆菌属、沙雷菌属、不动杆菌属和肠杆菌属的6株分离菌(共60株)对生理浓度的哌拉西林/他唑巴坦联合庆大霉素或环丙沙星的敏感性。他唑巴坦固定在4mg/L。根据时间杀菌曲线评估,庆大霉素加哌拉西林/他唑巴坦在2小时时对28株菌有协同作用,5小时时对51株菌有协同作用,24小时时对54株菌有协同作用;根据棋盘法评估,在24小时时对所有60株菌有协同或相加作用(FBC指数≤1)。环丙沙星加哌拉西林/他唑巴坦的相应数字分别为7、26、52和58。在24小时时,每种联合用药对1株菌表现出拮抗作用(FBC指数≥4)。每种抗生素联合用药的FIC指数和FBC指数之间没有显著差异。庆大霉素加哌拉西林/他唑巴坦在2小时时对47株菌有≥3个对数级的杀菌作用,5小时时对56株菌有≥3个对数级的杀菌作用,24小时时对59株菌有≥3个对数级的杀菌作用。环丙沙星加哌拉西林/他唑巴坦在2小时时对22株菌有≥3个对数级的杀菌作用,5小时时对36株菌有≥3个对数级的杀菌作用,24小时时对56株菌有≥3个对数级 的杀菌作用。总之,对于大多数测试菌株,两种抗生素联合用药在生理浓度下在24小时时具有协同或相加作用,尽管值得注意的是庆大霉素加哌拉西林/他唑巴坦杀菌速度更快。很少见到拮抗作用。两种联合用药可能对严重感染的治疗有益。

相似文献

1
In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin.哌拉西林/他唑巴坦与庆大霉素及环丙沙星的体外药效学研究
J Antimicrob Chemother. 1997 Jan;39(1):53-61. doi: 10.1093/jac/39.1.53.
2
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.哌拉西林、哌拉西林-他唑巴坦和环丙沙星单独及联合应用对金黄色葡萄球菌、肺炎克雷伯菌、阴沟肠杆菌和铜绿假单胞菌的体外药效学。
Antimicrob Agents Chemother. 1995 Aug;39(8):1711-6. doi: 10.1128/AAC.39.8.1711.
3
Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.哌拉西林/他唑巴坦与阿米卡星、环丙沙星和曲伐沙星联合对铜绿假单胞菌的时间杀菌活性。
Diagn Microbiol Infect Dis. 2000 Sep;38(1):37-41. doi: 10.1016/s0732-8893(00)00162-0.
4
Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles.哌拉西林/他唑巴坦对不列颠群岛住院患者分离细菌的体外活性比较的多中心调查。
J Antimicrob Chemother. 1993 Aug;32(2):247-66. doi: 10.1093/jac/32.2.247.
5
[Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].替卡西林-克拉维酸或其他β-内酰胺类抗生素(阿莫西林、哌拉西林-他唑巴坦、替卡西林)与庆大霉素联合使用对粪肠球菌和屎肠球菌的杀菌活性
Pathol Biol (Paris). 1995 Apr;43(4):245-52.
6
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.头孢吡肟、哌拉西林/他唑巴坦、庆大霉素、环丙沙星和左氧氟沙星单独及联合应用对铜绿假单胞菌的作用。
Diagn Microbiol Infect Dis. 2002 Sep;44(1):35-41. doi: 10.1016/s0732-8893(02)00420-0.
7
In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.加替沙星单独及与头孢吡肟、美罗培南、哌拉西林和庆大霉素联合对多重耐药菌的体外活性。
J Antimicrob Chemother. 2003 May;51(5):1203-11. doi: 10.1093/jac/dkg238. Epub 2003 Apr 14.
8
Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.哌拉西林-他唑巴坦与替卡西林-克拉维酸的体外活性比较
Antimicrob Agents Chemother. 1989 Aug;33(8):1268-74. doi: 10.1128/AAC.33.8.1268.
9
[Second multicenter study of the in vitro susceptibility to piperacillin-tazobactam].
Rev Esp Quimioter. 2002 Jun;15(2):169-75.
10
In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates.哌拉西林/他唑巴坦相对于其他抗生素对血培养分离株的体外活性。
Ir J Med Sci. 1998 Jul-Sep;167(3):155-9. doi: 10.1007/BF02937928.

引用本文的文献

1
Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.优化碳青霉烯类抗生素与氨基糖苷类抗生素联合使用以对抗耐碳青霉烯鲍曼不动杆菌的新方法。
Antimicrob Agents Chemother. 2015 Apr;59(4):2286-98. doi: 10.1128/AAC.04379-14. Epub 2015 Feb 2.
2
Antimicrobial treatment of serious gram-negative infections in newborns.新生儿严重革兰氏阴性感染的抗菌治疗。
Curr Infect Dis Rep. 2014 Feb;16(2):400. doi: 10.1007/s11908-014-0400-6.
3
Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro.
抗生素与植物化学物质组合对铜绿假单胞菌的体外活性及相互作用。
Int J Biol Sci. 2010 Sep 21;6(6):556-68. doi: 10.7150/ijbs.6.556.
4
In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.体外协同抗生素组合对多重耐药铜绿假单胞菌的疗效。
Yonsei Med J. 2010 Jan;51(1):111-6. doi: 10.3349/ymj.2010.51.1.111. Epub 2009 Dec 29.
5
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.哌拉西林/他唑巴坦:其在治疗细菌感染中的应用最新综述
Drugs. 1999 May;57(5):805-43. doi: 10.2165/00003495-199957050-00017.
6
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.嗜麦芽窄食单胞菌相关感染的微生物学及临床方面
Clin Microbiol Rev. 1998 Jan;11(1):57-80. doi: 10.1128/CMR.11.1.57.